PPL vs RNAC · P/E 22, rev $8.46B vs P/E 2.1, rev $38.9M
PPL Corporation (PPL) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
PPL currently screens at market cap $26.58B and trailing P/E 21.7. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the PPL and RNAC stock pages for the full models.
Not investment advice.